
    
      Patients will be treated with OSI-774 (orally) daily, oxaliplatin (intravenously) every 3
      weeks, and capecitabine (orally) twice daily for 14 days followed by a 7-day rest period.
      This will constitute a 21-day treatment cycle. Treatment will continue until disease
      progression or unacceptable toxicity occurs.
    
  